The pharmaceutical company “Darnitsa” is not considering relocating production, according to Kateryna Zagoriy, chair of the company’s board of directors.
“I wouldn’t say it’s impossible to relocate our pharmaceutical production—because a lot is possible—but it’s complicated and expensive. It’s a very complex construction project that requires, for example, not only shelters and generators but also several artesian wells and a whole range of other highly specialized and time-consuming construction work. My lesson is this: be prepared for the fact that everyone will be on high alert as long as Russia is our enemy,” Zagoriy said during the Kyiv International Economic Forum.
She noted that “about 5 minutes before that first flight, and about 20 minutes before the second, we were warned by our security agencies.”
“We have shelters, safe havens, protocols—we have 100 to 500 procedures, ranging from healthcare to alerting people, covering every possible measure. We have no casualties, thanks to God and the Armed Forces of Ukraine. You have to ask yourself whether you’re safer at home. And you start to find motivation in the fact that it’s actually safer to go to work, because the shelter is only 90 seconds away,” said Zagoriy.
As previously reported, the pharmaceutical company “Darnitsa” suffered three strikes by Russian occupiers throughout September. In addition, the production facilities of the company’s pharmaceutical plant were damaged during a massive Russian ballistic missile attack on Kyiv in June of this year.
